PubRank

Singapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia (SINGA-PACLI) Trial (SINGA-PACLI)

Clinical Trial ID NCT02129634

PubWeight™ 0.75‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02129634

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004 11.86
2 Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005 7.25
3 Coronary-artery stents. N Engl J Med 2006 4.13
4 Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008 3.21
5 Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005 3.06
6 International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ 2010 2.57
7 Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 2008 2.41
8 Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 2005 2.00
9 Introduction to health economics for physicians. Lancet 2001 1.90
10 First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol 2011 1.78
11 Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004 1.76
12 Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. J Endovasc Ther 2012 1.68
13 Self-expanding nitinol stents in recanalisation of long-length superficial femoral artery occlusions in patients with critical limb ischaemia. Singapore Med J 2009 1.38
14 Quality of life following lower limb amputation for peripheral arterial disease. Eur J Vasc Surg 1993 1.15
15 PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol 2010 0.96
16 The costs of managing lower limb-threatening ischaemia. Eur J Vasc Endovasc Surg 1996 0.94
17 The role of infrapopliteal angioplasty. Br J Radiol 2004 0.92
18 Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther 2005 0.89
19 Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation 2005 0.88
20 The effects of successful intervention on quality of life in patients with varying degrees of lower-limb ischaemia. Eur J Vasc Endovasc Surg 2000 0.87
21 The effects of paclitaxel on the three phases of restenosis: smooth muscle cell proliferation, migration, and matrix formation: an in vitro study. Invest Radiol 2004 0.85
22 A systematic review of lower extremity arterial revascularization economic analyses. J Vasc Surg 2011 0.80
23 Paclitaxel-eluting stents in complex lesions. JAMA 2005 0.78
24 Always contact a vascular interventional specialist before amputating a patient with critical limb ischemia. Cardiovasc Intervent Radiol 2009 0.75
25 Should we save critically ischaemic legs at any cost? Acta Chir Belg 2009 0.75
26 Peripheral arterial disease and diabetes foot care. Singapore Med J 2008 0.75
27 Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date. Vasc Health Risk Manag 2016 0.75
Next 100